Daclatasvir Dihydrochloride and Polatuzumab Vedotin-piiq
Determining the interaction of Daclatasvir Dihydrochloride and Polatuzumab Vedotin-piiq and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: polatuzumab vedotin
Brand name: Polivy
Synonyms: Polatuzumab vedotin, Polatuzumab Vedotin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Polio vaccine, inactivated
- Daclatasvir Dihydrochloride-Poliovirus Vaccine (Inactivated)
- Daclatasvir Dihydrochloride-Poliovirus vaccine, inactivated Injection
- Daclatasvir Dihydrochloride-Polivy
- Daclatasvir Dihydrochloride-Polmon
- Daclatasvir Dihydrochloride-Polocaine
- Polatuzumab Vedotin-piiq-Daclizumab
- Polatuzumab Vedotin-piiq-Daclizumab Subcutaneous
- Polatuzumab Vedotin-piiq-Dacogen
- Polatuzumab Vedotin-piiq-Dacomitinib
- Polatuzumab Vedotin-piiq-Dactinomycin
- Polatuzumab Vedotin-piiq-Dactinomycin Injection